John Flavin

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John Flavin

John Flavin was last confirmed as Board Member at Pyxis Oncology, Inc. (PYXS) in a filing dated April 28, 2023. Pyxis Oncology, Inc. reported in an 8-K filed September 8, 2026 that John Flavin was appointed Lead Independent Director, effective September 4, 2026.

“the Board established the position of Lead Independent Director and appointed Mr. Flavin to serve in that role, effective September 4, 2026.”

Pyxis Oncology, Inc. Form 8-K, filed September 8, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize John Flavin's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Pyxis Oncology, Inc. (PYXS)
Board Member

Proxy statement

2019-01-01–2023-04-28

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Pyxis Oncology, Inc.

PYXS

Board Member

Since 2019-01-01, last confirmed 2023-04-28

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Lead Independent Director Pyxis Oncology, Inc. (PYXS)
2026-09-04